Jan van Busschbach

13PUBLICATIONS
56CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Clinical psychologyPacific Peoples and disabilityMedical infection agents (incl. prions)Adolescent health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 27, 2026
A Multicenter Phase II Randomized Controlled Trial Comparing 177Lu-Dotatate/Capecitabine Combination Treatment with 177Lu-Dotatate Monotherapy in Patients with Neuroendocrine Tumors.

Morticia N Becx, Johannes Hofland, Eric P Krenning

|Aug 18, 2025
The impact of vitreous floaters on quality of life: a qualitative study.

Jarinne E Woudstra-de Jong, Sonia S Manning-Charalampidou, Johannes Hans R Vingerling

|Aug 04, 2025
A Mixed-method Study on the Implementation of a Medical Psychiatric Care Unit.

Chedwa Pinto, Maaike Meeder, Jan Busschbach

|Jul 27, 2024
Psychometric validation of the Chinese versions of EQ-5D-Y-3L and the experimental EQ-TIPS in children and adolescents with COVID-19.

Wenjing Zhou, Yaqin Li, Jan Busschbach

|May 15, 2024
Eye Movement Desensitization and Reprocessing (EMDR) treatment in the medical setting: a systematic review.

Helen P A Driessen, Sid Morsink, Jan J V Busschbach

Pageof 3